We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock
NURO

Delisted

NURO was delisted on the 1st of May, 2025.

Back to rankings

17 hedge funds and large institutions have $2.07M invested in NeuroMetrix, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

1% more capital invested

Capital invested by funds: $2.04M → $2.07M (+$29K)

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$112K
2
Citadel Advisors
Citadel Advisors
Florida
+$89.7K
3
Renaissance Technologies
Renaissance Technologies
New York
+$52.2K
4
TSS
Two Sigma Securities
New York
+$44.3K
5
Northern Trust
Northern Trust
Illinois
+$41.3K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$78K
2
BlackRock
BlackRock
New York
-$7.46K
3
TRCT
Tower Research Capital (TRC)
New York
-$2K
4
Morgan Stanley
Morgan Stanley
New York
-$1.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.16M – – –
Geode Capital Management
2
Geode Capital Management
Massachusetts
$202K +$3.85K +129 +2%
Renaissance Technologies
3
Renaissance Technologies
New York
$162K +$52.2K +1,748 +46%
BlackRock
4
BlackRock
New York
$140K -$7.46K -250 -5%
Bank of America
5
Bank of America
North Carolina
$111K +$112K +3,738 +12,058%
Citadel Advisors
6
Citadel Advisors
Florida
$88K +$89.7K +3,006 New
State Street
7
State Street
Massachusetts
$67K +$3.34K +112 +5%
TSS
8
Two Sigma Securities
New York
$44K +$44.3K +1,485 New
Northern Trust
9
Northern Trust
Illinois
$41K +$41.3K +1,382 New
Osaic Holdings
10
Osaic Holdings
Arizona
$37K – – –
TAM
11
Tucker Asset Management
Colorado
$13.3K +$836 +28 +7%
SC
12
Stephens Consulting
Michigan
$1.84K – – –
Morgan Stanley
13
Morgan Stanley
New York
$1K -$1.1K -37 -66%
IA
14
IFP Advisors
Florida
$1K – – –
UBS Group
15
UBS Group
Switzerland
$1K +$687 +23 +79%
VF
16
Virtu Financial
New York
– -$78K -2,335 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$2K -72 Closed
Wells Fargo
18
Wells Fargo
California
– +$30 +1 +20%

NURO Hedge Fund Activity: Q2 2022 in Review

17 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2022, worth a combined $2.07M — up 1.4% from $2.04M a quarter earlier.

Fund positioning in NURO was balanced in Q2 2022: 3 funds opened new positions, 3 closed out, 7 added to existing stakes and 2 trimmed.

The largest buyer was Bank of America, adding an estimated $112K. The largest seller was Virtu Financial, exiting entirely with an estimated $78K sold.

  • 17 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2022, unchanged from Q1 2022.
  • Funds reported $2.07M of NeuroMetrix, Inc. Common Stock stock for Q2 2022, up 1.4% quarter-over-quarter.
  • 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2022 and 3 closed out, a net change of 0 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2022 was Bank of America, an estimated $112K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2022 was Virtu Financial, an estimated $78K sold.

Based on aggregated 13F filings for Q2 2022.